Study to Evaluate the Efficacy and Safety of Treatment With Bendamustine in Combination With Ofatumumab in Previously Untreated Patients With Indolent B-Cell Non-Hodgkin's Lymphoma (NHL)
Public ClinicalTrials.gov record NCT01108341. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label Study to Evaluate the Efficacy and Safety of Treatment With Bendamustine in Combination With Ofatumumab in Previously Untreated Patients With Indolent B-Cell Non-Hodgkin's Lymphoma (NHL)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of the study is to determine the efficacy, as measured by overall response (complete response + partial response) of bendamustine in combination with ofatumumab in previously untreated patients with indolent B-Cell Non-Hodgkin's Lymphoma (NHL).
Study identification
- NCT ID
- NCT01108341
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 50 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2010 (Type not available)
- Primary completion
- Jul 2011 (Actual)
- Completion
- Oct 2011 (Actual)
- Last update posted
- Aug 28, 2012
2010 – 2011
United States locations
- U.S. sites
- 34
- U.S. states
- 21
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Birmingham Hematology and Oncology Associates, LLC | Birmingham | Alabama | 35235 | — |
| University of Alabama at Birmingham | Birmingham | Alabama | 35294-3300 | — |
| Tower Cancer Research Foundation | Beverly Hills | California | 90211-1850 | — |
| Hematology Oncology, P.C. | Stamford | Connecticut | 06902 | — |
| University Cancer Institute | Boynton Beach | Florida | 33435 | — |
| Florida Cancer Institute - New Hope | New Port Richey | Florida | 34655 | — |
| Dublin Hematology Oncology Care P.C. | Dublin | Georgia | 31021 | — |
| Northwest Georgia Oncology Center | Marietta | Georgia | 30060 | — |
| Georgia Cancer Specialists | Tucker | Georgia | 30084 | — |
| Cancer Care and Hematology Specialists of Chicagoland | Niles | Illinois | 60714 | — |
| Siouxland Hematology-Oncology Assoc. LLP | Sioux City | Iowa | 51101 | — |
| Kentucky Cancer Clinic | Hazard | Kentucky | 41701 | — |
| Carroll County Cancer Center | Westminster | Maryland | 21157 | — |
| Columbia Comprehensive Cancer Care Clinic | Jefferson City | Missouri | 65109 | — |
| Nevada Cancer Institute | Las Vegas | Nevada | 89135 | — |
| Somerset Hematology Oncology Associates | Somerville | New Jersey | 08876 | — |
| Roswell Park Cancer Institute | Buffalo | New York | 14263 | — |
| Monter Cancer Center | Lake Success | New York | 11042 | — |
| Mid Dakota Clinic | Bismarck | North Dakota | 58504 | — |
| Oregon Health Sciences University | Portland | Oregon | 97239 | — |
| University of Pittsburgh Medical Center - Cancer Institute | Pittsburgh | Pennsylvania | 15232 | — |
| Cancer Centers of the Carolinas | Greenville | South Carolina | 29605 | — |
| The West Clinic | Memphis | Tennessee | 38138 | — |
| Texas Oncology, P.A. | Bedford | Texas | 76022 | — |
| MD Anderson Cancer Center | Houston | Texas | 77030-4009 | — |
| Longview Cancer Center | Longview | Texas | 75601 | — |
| Joe Arrington Cancer Research | Lubbock | Texas | 79410 | — |
| Texas Oncology, P.A. | McAllen | Texas | 78503 | — |
| Cancer Care Centers of South Texas | San Antonio | Texas | 78229 | — |
| Texas Oncology | Waco | Texas | 76712 | — |
| Texas Oncology, P.A. | Webster | Texas | 77598 | — |
| US Oncology Research - Texoma Cancer Center | Wichita Falls | Texas | 76310 | — |
| Fairfax/Northern Virginia Hematology/Oncology | Fairfax | Virginia | 22031 | — |
| Yakima Valley Memorial Hospital/North Start Lodge | Yakima | Washington | 98902 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01108341, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 28, 2012 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01108341 live on ClinicalTrials.gov.